Tarsus Pharmaceuticals, Inc. (TARS)
62.99
-0.49
(-0.77%)
USD |
NASDAQ |
May 22, 13:52
Tarsus Pharmaceuticals Total Assets (Quarterly) : 581.14M for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Harrow, Inc. | 419.54M |
| Eton Pharmaceuticals, Inc. | 97.71M |
| ANI Pharmaceuticals, Inc. | 1.422B |
| Corcept Therapeutics, Inc. | 814.88M |
| Assertio Holdings, Inc. | 211.30M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 232.18M |
| Shareholders Equity (Quarterly) | 348.95M |
| Debt to Equity Ratio | 0.2541 |
| Current Ratio | 3.744 |
| Net Debt Paydown Yield | -0.11% |